HomeContact

SEWON Cellontech Co., Ltd.


Tissue engineering, cord blood cell banking, ACT, biomaterials


SEWON Cellontech Co., Ltd. was registred in 2000 and a cell therapy factory and a cord blood bank were established. Chondron® was approved by the Korean Food and Drug Administration (KFDA) in 2001 as the first biotechnology product in Korea. Good Manufacturing Practice was aquired. In the same year SEWON Cellontech became a venture company. In 2002, AusBio (Australia) and CellonTech signed an agreement in relation to Chondron®.


Dong-sam Seo, Dr., CEO


Cheong-Ho Chang, Chairman


10,11th Fl, Goodmorning-shinhan Tower
23-2 Yoido-Dong,
Youngdeungpo-gu,
Seoul, 150-712,
Korea
Phone: +82-02-2167-9000
Fax: +82-02-2167-9157


Today, SEWON Cellontech’s main business areas include cell therapy engineering, cell and tissue bank engineering and biomaterial engineering.SEWON Cellontech’s research centre deals with issues such as mesenchymal stem cells (MSC), haematopoetic stem cells (HSC), nano biomaterials and medical sciences.

The leading products in the field of cell therapy engineering are: Chondron®: autologous in vitro cultured chondrocytes for autologous chondrocyte transplantation (ACT); it is used to stimulate the growth of the patients own cartilage cells.
Ostem®, for autologous osteoblast transplantation, is pending for KFDA approval; Hemstem®, Dendron®, Derman® are designed for autologous and allogenic haematopoetic stem cell, dendric cell and skin transplantation.

In the business area Cell & Tissue Bank Engineering Cellontech offers two programmes: The “Baby Cell Program” is a cord blood banking system and the “Allo Tissue Program” is a bank for allogeneic tissues.

Biomaterial engineering products include Theracol® (pending for KFDA approval), a collagen matrix product in order to accelerate the healing of tissue defects, and Joint Joy®, a glucosamine juice for arthritis patients.

The following section contains a selection of the company’s most relevant patents. For comprehensive patent information please refer to the espacenet databases.